Case Study: Dasa advances personalized cancer care with SOPHiA GENETICS multimodal data solutions

DASA accelerates oncology insights across 20 million patients with SOPHiA GENETICS

DASA, a major diagnostic medicine network in Brazil, sought to better understand how to orient its patients toward personalized medicine and optimize the use of oncology data collected throughout the patient diagnostic journey. To meet this challenge, DASA partnered with SOPHiA GENETICS and adopted its solutions, including SOPHiA DDM™ for Radiomics and SOPHiA DDM™ Trial Match.

By implementing the multimodal approach from SOPHiA GENETICS, DASA accelerated clinical trial recruitment informed by biomarkers and saw an exponential growth in the number of genomic analyses performed. The SOPHiA DDM™ platform also enabled DASA’s radiologists and oncologists to make more data-driven decisions and provide individualized patient follow-up, helping clinicians better understand how to treat and orient patients toward personalized medicine.

DASA